Quantitative PSMA PET Biomarkers for Predicting Response to &lt;sup&gt;177&lt;/sup&gt;Lu-PSMA Therapy in Prostate Cancer: A Systematic Review and Meta-analysis. The gene discussed is FOLH1; the disease is prostate carcinoma.